News

Branded products are 92% US market in dollar value, says IMS Institute

Prestigious competition for budding scientists takes a biotech vibe

Pilot program in Rwanda has commercial potential

Trend toward outcomes-based pharma contracts could be accelerated

Bloomberg BusinessWeek rakes over charitable copay programs

Looming EU IDMP mandates are only part of the potential applications

The growing compliance requirements for distribution call for a streamlined approach

Practice Fusion taps into a 38-million-patient database

Few new treatments are available while antibiotic resistance is growing, says Pew Charitable Trust

Company pursues ‘bench to bedside’ commercialization services

Deals with Amgen and Sanofi/Regeneron enhance new pricing policies for specialty drugs

Dispense As Written

Demand for cryogenic logistics propels business growth

Program seeks to improve care while reducing costs

Site opens up a Facebook-like “Pages” to vendors and medical organizations

Managed care organizations are adjusting rapidly to onslaught of specialty products

A raft of new therapies is generating renewed optimism for cancer care, but even as lower-cost biosimilars enter the market, cost is a crippling factor

Packaging designers continue the uphill battle for converting the US pharma industry to unit-dose, compliance-improving packaging

New IT data-science and visualization tools advance supply chain management

Policymakers look at alternative payment models in oncology

The SP channel continues to grow, with manufacturers looking for more control over access

Sharing clinical data—EvGen—will improve both drug development and health outcomes analysis

Pharma spends heavily to secure its supply chain, while politicians bring out the re-importation topic